2018-04-13
News
In a pressrelease distributed April 12, 2018 Intervacc presented information about the outcome of the preferential share issue of Intervacc AB (publ) ("Intervacc" or "Company") that was announced on February 18, 2018. ... Read more
2017-09-25
News
"Getting to grips with strangles" is a regularly recurring international scientific meeting on research on strangles a highly contagious horse disease. At the meeting held in Montanan, USA, in September 2017, Intervacc's CEO, Jan-Ingmar Flock, ... Read more
2017-08-01
News
The WEAS (World Equine Airway Symposium) is a regularly recurring international ... Read more
2017-03-01
News
2016-09-21
News
A series of trials have been conducted at the Animal Health Trust, Newmarket, England. The trials were aimed to measure the safety, immunogenicity, efficacy and DIVA (differentiates infected from vaccinated animals) ... Read more
2015-10-28
News
Intervacc is pleased to announce that an agreement has now been signed with PX´Therapeutics, Grenoble, France, for process optimization of Strangvac. PX´Therapeutics, a subsidiary of Aguettant pharmaceutical group, has the ... Read more